Ariad Pharmaceuticals Management Discusses Q2 2012 Results - Earnings Call Transcript
Ariad Pharmaceuticals (ARIA)
Q2 2012 Earnings Call
August 02, 2012 8:30 am ET
Executives
Maria E. Cantor - Senior Vice President of Corporate AffairsHarvey J. Berger - Principal Founder, Chairman of the Board, Chief Executive Officer, President and Chairman of Executive CommitteeEdward M. Fitzgerald - Chief Financial Officer, Principal Accounting Officer, Executive Vice President and TreasurerAnalystsMatthew Harrison - UBS Investment Bank, Research DivisionY. Katherine Xu - William Blair & Company L.L.C., Research DivisionRyan Martins - Lazard Capital Markets LLC, Research DivisionMichael J. Yee - RBC Capital Markets, LLC, Research DivisionJoel D. Sendek - Stifel, Nicolaus & Co., Inc., Research DivisionEileen Flowers - Jefferies & Company, Inc., Research DivisionYing Huang - Barclays Capital, Research DivisionMichael G. King - Rodman & Renshaw, LLC, Research DivisionPhilip Nadeau - Cowen and Company, LLC, Research DivisionHoward Liang - Leerink Swann LLC, Research DivisionKaren E. Jay - JP Morgan Chase & Co, Research DivisionRachel L. McMinn - BofA Merrill Lynch, Research DivisionEcho Yinghui He - Maxim Group LLC, Research DivisionPresentationOperatorPrevious Statements by ARIA
» ARIAD Pharmaceuticals CEO Discusses Q3 2010 - Earnings Call Transcript
» ARIAD Pharmaceuticals, Inc. Q2 2010 Earnings Call Transcript
» ARIAD Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
